Four things to know:
1. In 2019, the market was valued at $1.1 billion.
2. A rise in approvals and product launches is expected to boost the market during the forecast period.
3. Recent developments in the market include Centinel Spine gaining FDA approval for a two-level clinical trial of its Prodisc C anterior cervical total disc devices and Zimmer Biomet launching its Mobi-C cervical disc in Japan.
4. Ongoing clinical trials for the treatment of degenerative disc disease is contributing to the growth of the Asia Pacific market.
More articles on devices:
Dr. Daniel Yoshor excited by new challenge at Penn Medicine
New York neurosurgeon recovers from COVID-19, volunteers at hospital ICU
Neurosurgeon, dentist’s 3D printed masks evolved production, being made worldwide: 5 details
